Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2005
09/28/2005EP1578771A2 Remodeling and glycoconjugation of peptides
09/28/2005EP1578745A1 Benzofuran derivates, process for their preparation and intermediates thereof
09/28/2005EP1578728A1 5-aminophenanthridine derivatives as npy-5 antagonists
09/28/2005EP1578725A1 Microsomal triglyceride transfer protein inhibitors
09/28/2005EP1578716A1 Dicarboxylic acid derivatives as ppar-agonists
09/28/2005EP1578448A1 Compositions of cholesteryl ester transfer protein inhibitors and hmg-coa reductase inhibitors
09/28/2005EP1578437A1 Compositions and methods for the prevention and control of insulin-induced hypoglycemia
09/28/2005EP1463731B1 Dibenzodiazepine derivates, their preparation and use
09/28/2005EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes
09/28/2005EP1299365B1 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/28/2005EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
09/28/2005EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof
09/28/2005EP1265838B1 Novel fatty acid analogous
09/28/2005EP1259622B1 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method
09/28/2005EP1243583B1 Heterocyclic compounds having sulfonamide groups
09/28/2005EP1242397B1 Trans olefinic glucokinase activators
09/28/2005EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
09/28/2005EP1178781B1 Multilayer pharmaceutical product for release in the colon
09/28/2005EP1165510B1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
09/28/2005EP1000085B1 Treatment of insulin resistance with growth hormone secretagogues
09/28/2005CN1675344A Oil or fat composition
09/28/2005CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
09/28/2005CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
09/28/2005CN1675233A Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides
09/28/2005CN1675229A Sulfur-containing phospholipid derivatives
09/28/2005CN1675224A Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675222A C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675213A 新的嘌呤衍生物 New purine derivatives
09/28/2005CN1675212A 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
09/28/2005CN1675211A 新的嘌呤衍生物 New purine derivatives
09/28/2005CN1675210A Substituted 2, 4-dihydro-pyrrolo[3, 4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
09/28/2005CN1675209A Dihydropyrazolopyridine compounds
09/28/2005CN1675208A Novel fused imidazole derivative
09/28/2005CN1675205A Novel quinuclidine derivatives and their use
09/28/2005CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
09/28/2005CN1675200A Process for preparing 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
09/28/2005CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
09/28/2005CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
09/28/2005CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/28/2005CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase
09/28/2005CN1675192A Novel compunds, pharmaceutical compositions containing same, and methods of use for same
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675184A Caspase inhibitors and uses thereof
09/28/2005CN1675181A 2, 3-dihydro-isoindol-1-ones with MAO-B inhibiting activity
09/28/2005CN1675180A Indole, indazole, and benzazole derivative
09/28/2005CN1675173A Muscarinic agonists
09/28/2005CN1675171A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/28/2005CN1675159A Method and device for producing formic acid formates and use of said formates
09/28/2005CN1674959A Use of a PPAR-alpha agonist to treat weight gain associated with a PPAR-gamma agonist treatment
09/28/2005CN1674937A Remedy or preventive for kidney disease and method of diagnosing kidney disease
09/28/2005CN1674931A T cell receptor CDR3 sequences and methods for detection
09/28/2005CN1674927A Growth hormone releasing peptides
09/28/2005CN1674926A Remedy
09/28/2005CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis
09/28/2005CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
09/28/2005CN1674914A Female hormone-containing patch
09/28/2005CN1674900A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion
09/28/2005CN1674897A Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as HPPAR activators
09/28/2005CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/28/2005CN1674883A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
09/28/2005CN1674868A Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent
09/28/2005CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
09/28/2005CN1673380A Phosphoric acid receptor protein gene glandular related viral vector and construction and application
09/28/2005CN1672718A 橄榄钙片 Olive calcium
09/28/2005CN1672712A New recipe and prepn process of blood fat reducing medicine
09/28/2005CN1672690A Shengu dispersive tablet and its prepn process
09/28/2005CN1672683A Hyperlipidemia treating composition
09/28/2005CN1220705C Alpha-lipoic acid and its derivative modified insulin and preparing method thereof
09/28/2005CN1220704C Cholalic acid derivative medified insulin and preparing method thereof
09/28/2005CN1220702C Insulinotropic peptide and its use
09/28/2005CN1220699C Polypeptide for inhibiting growth and migration of blood vessel endothelial cell and endothelial stem cell and its preparing method and use
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220505C Freeze-dried garlic powder preparation and its preparation method
09/28/2005CN1220497C Antivirus antioxidizing active extract of proplis and its molecular clathrate compound preparation
09/28/2005CN1220488C Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction
09/28/2005CN1220451C 健康食品 Healthy Food
09/27/2005US6949656 Cyclic amine derivatives and use thereof
09/27/2005US6949655 Acyclic piperidine derivatives
09/27/2005US6949585 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents
09/27/2005US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders
09/27/2005US6949579 Central nervous system disorders; antidiabetic agents
09/27/2005US6949578 useful in selectively inhibiting or antagonizing the alpha v beta 3 and/or alpha v beta 5 integrins; treatment of osteoporosis, humoral hypercalcemia of malignancy, Paget's disease, tumor metastasis, solid tumor growth (neoplasia), angiogenesis
09/27/2005US6949575 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
09/27/2005US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
09/27/2005US6949572 Antilipemic or antilipolytic agents for treatment of obesity and lipid disorders, S)-N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide
09/27/2005US6949565 Protein kinase inhibitors
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949555 Use of organic compounds
09/27/2005US6949547 Antidiabetic agents; central nervous system disorders; cardiovascular disorders; hypotensive agents; anticancer agents
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949535 for example, 2-(6-aminopurin-9-ylmethyl)-3-(2-chlorophenyl)-6,7-dimethoxy-3H-quinazolin-4-one
09/27/2005US6949515 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases
09/27/2005US6949356 Methods for improving secondary metabolite production in fungi
09/27/2005US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF
09/27/2005US6949259 Solid preparations for oral use
09/22/2005WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient
09/22/2005WO2005087749A1 2-aminoquinazoline derivative
1 ... 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 ... 1298